Table 2

Descriptive data—intervention study 

Intervention cohortsNorth metropolitan (intervention cohort)
n=187
South metropolitan (control)
n=149
Cohort comparisons
Time of simulated patient assessment (preintervention or postintervention)Pre, count (%)Post, count (%)p Value comparing pre to post of intervention cohortPre, count (%)Post, count (%)p Value comparing pre to post of control cohortp Value comparing differences in time between cohorts
Counsellor demographics
 Position of first counsellor*
  Pharmacist55 (29.4)55 (29.4)NS33 (22.2)44 (29.5)NSNS
  Pharmacy assistant31 (16.6)38 (20.3)NS37 (24.8)29 (19.5)NSNS
  Other10 (5.3)7 (3.7)NS17 (11.4)9 (6.0)NSNS
  Unsure91 (48.7)87 (46.5)NS62 (41.6)67 (45.0)NSNS
 Change in counsellor (when first consultant was a pharmacy assistant at both time points)*
  No change5 (83.3)4 (66.7)NS8 (66.7)7 (58.3)NSNS
  Assistant to pharmacist0 (0.0)1 (16.7)NS3 (25.0)1 (8.3)NSNS
  Pharmacist consulted1 (16.7)1 (16.7)NS1 (8.3)4 (33.3)NSNS
Consultation details
 Waiting time (busyness measure)†
  None155 (82.9)170 (90.9)0.0236124 (83.2)135 (90.6)0.0428NS
  1–5 min31 (16.6)16 (8.6)NS25 (16.8)13 (8.7)NS
  Over 5 min1 (0.5)1 (0.5)NS0 (0.0)1 (0.7)NS
Patient assessment
 Questions (frequently asked)
  Is this product for you?125 (66.8)124 (66.3)NS124 (83.2)111 (74.5)NSNS
  Have you used this product before?77 (40.1)58 (31.0)NS67 (45.0)50 (33.6)0.0467NS
  How often are you using your reliever?60 (32.1)71 (38.0)NS63 (42.3)54 (36.2)NSNS
  Have you had a review by a doctor?48 (25.7)45 (24.1)NS43 (28.9)27 (18.2)NSNS
  Are you using a preventer?24 (12.8)92 (49.2)<0.000132 (21.5)88 (59.1)<0.0001NS
Inhaler technique questions asked
 When did you last have your device technique checked?1 (0.5)0 (0.0)Not performed0 (0.0)0 (0.0)Not performedNot performed
 Can you show me your technique?1 (0.5)2 (1.1)Not performed0 (0.0)0 (0.0)Not performed
 Demonstration of technique
  Device technique demonstrated (NB: Demonstrated technique in all instances was incorrect)2 (1.1)1 (0.5)Not performed0 (0.0)0 (0.0)Not performed
Medication counselling information provided
 Information given (most frequently)
  Information given on dosage20 (10.7)25 (13.3)NS19 (12.8)15 (10.1)NSNS
  Information given on duration/frequency of use13 (7.0)34 (18.1)0.001325 (16.8)26 (17.4)NS0.0201
 Discussions about medical referral
  Referral to a healthcare professional59 (31.6)0.000775 (50.3)65 (43.6)NS0.0019
  Immediate referral recommended (when referred)5 (8.5)NS6 (8.0)8 (12.3)NSNS
  Reason for referral given (when referred)*
   Uncontrolled asthma17 (28.8)21 (24.1)NS15 (20.0)14 (21.5)NSNS
   Overuse of reliever medication26 (44.1)37 (42.5)NS30 (40.0)22 (33.9)NSNS
   No medical assessment <6 months4 (6.8)6 (6.9)NS4 (5.3)8 (12.3)NSNS
   Lack of written asthma action plan0 (0.0)2 (2.3)NS2 (2.7)3 (4.6)NSNS
Resources used in patient interactions
 Use of Asthma Medication Request Checklist introduced as part of intervention
  Patient asked to fill in the checklistNA2 (1.1)Not performed0 (0.0)0 (0.0)Not performedNot performed
  Explanation of checklist purpose was offeredNA2 (1.1)Not performed0 (0.0)0 (0.0)Not performed
  • ‘Counsellor’ refers to the pharmacy staff member interacting with the patient.

  • *Each analysis with this variable was performed as the individual category versus the rest.

  • †This analysis was performed as: no waiting time versus waiting time due to limited numbers in the ‘over 5 min’ category.

  • NS, not significant; pre, preintervention; post, postintervention.